Gelesis' Unattributed VC Round

Gelesis raised a round of funding on April 18, 2007. Investors include Queensland BioCapital Funds.

Gelesis is developing a smart pill (Gelesis100) to fulfill the unmet need for a product that can safely cause significant weight loss. Gelesis100 was developed for overweight and obese individuals as …

Articles about Gelesis' Unattributed VC Round: